Don't Confuse the New Quinolone Baxdela for Other "Floxacin" Antibiotics

Baxdela (baks-DEH-lah, delafloxacin) will be the latest "quinolone" antibiotic.

It'll be saved as a last resort for certain skin infections...such as those caused by methicillin-resistant Staph aureus (MRSA).

Expect most patients on Baxdela to get 450 mg by mouth...or 300 mg IV...every 12 hours for 5 to 14 days. Therapy length will depend on the severity and type of skin infection being treated.

Get unlimited access through an Enterprise license

Hospital Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals